A phase I/II trial of Cabozantinib in combination with Durvalumab MEDI4736 with or without Tremelimumab in patients with advanced gastroesophageal cancer and other gastrointestinal GI malignancies CAMILLA

Brief Summary

Type:
Other

Study Type:
Treatment

Phase:
I/II

ClinicalTrials.gov Identifier:
NCT03539822

Study #:
STUDY00141879

Start Date:
Sep 13, 2018

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

ClinicalTrials.gov ID: NCT03539822

View Complete Trial Details & Eligibility at ClinicalTrials.gov